Compound
D0604 | 1-benzyl-1-{[3-(4-chlorophenyl)-5-methyl-1-benzofuran-2-yl]methyl}-3-(2,4,6-trifluorophenyl)urea
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 21.01±2.43 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 56.23 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | rat | hepatocytes | MMP assay | Negative | IC50 | 163 | ||
| 146011-65-6 | CAS-146011-65-6; | CHEMBL3187915 |
| DSSTox_CID_28145 | DSSTox_GSID_48171 | DSSTox_RID_82710 |
| DTXSID6048171 | FR 145237 | FR-145237 |
| FR145237 | NCGC00257446-01 | SCHEMBL5500482 |
| Tox21_303375 |
| CAS Number | 146011-65-6 |
| PubChem Compound | 9850056 |